Slingshot members are tracking this event:
GlycoMimetics Releases Initial Clinical Data from Phase 1 GMI-1271 Study of Patients with Acute Myeloid Leukemia
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Mar 02, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Initial Phase 1 Clinical Data, Gmi-1271, Acute Myeloid Leukemia